Alkermes
ALKS
#2140
Rank
โ‚ฌ8.06 B
Marketcap
48,36ย โ‚ฌ
Share price
4.26%
Change (1 day)
98.23%
Change (1 year)

Revenue for Alkermes (ALKS)

Revenue in 2026 (TTM): โ‚ฌ1.33 Billion

According to Alkermes's latest financial reports the company's current revenue (TTM ) is โ‚ฌ1.37 Billion. In 2025 the company made a revenue of โ‚ฌ1.25 Billion a decrease over the revenue in the year 2024 that were of โ‚ฌ1.49 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Alkermes from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚ฌ1.33 B6.19%
2025 โ‚ฌ1.25 B-16.06%
2024 โ‚ฌ1.49 B-0.52%
2023 โ‚ฌ1.50 B45.18%
2022 โ‚ฌ1.03 B0%
2021 โ‚ฌ1.03 B22.72%
2020 โ‚ฌ0.84 B-19.21%
2019 โ‚ฌ1.04 B9.28%
2018 โ‚ฌ0.95 B27.05%
2017 โ‚ฌ0.75 B6.2%
2016 โ‚ฌ0.70 B23.37%
2015 โ‚ฌ0.57 B12.95%
2014 โ‚ฌ0.50 B
2012 โ‚ฌ0.41 B71.49%
2011 โ‚ฌ0.23 B82.88%
2010 โ‚ฌ0.13 B2.02%
2009 โ‚ฌ0.12 B-48.11%
2008 โ‚ฌ0.24 B48.35%
2007 โ‚ฌ0.16 B-3.95%
2006 โ‚ฌ0.17 B51.05%
2005 โ‚ฌ0.11 B125.1%
2004 โ‚ฌ50.99 M81.97%
2003 โ‚ฌ28.02 M-38.43%
2002 โ‚ฌ45.51 M-21.71%
2001 โ‚ฌ58.13 M22.99%
2000 โ‚ฌ47.26 M91.21%
1999 โ‚ฌ24.72 M-36.47%
1998 โ‚ฌ38.91 M64.99%
1997 โ‚ฌ23.58 M52.89%
1996 โ‚ฌ15.42 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ84.60 B 6,067.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ49.67 B 3,521.46%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ55.58 B 3,952.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ48.69 B 3,449.97%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚ฌ42.56 B 3,003.31%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ53.06 B 3,768.59%๐Ÿ‡ฌ๐Ÿ‡ง UK
Zogenix
ZGNX
โ‚ฌ71.72 M-94.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
โ‚ฌ0.10 B-92.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ15.23 B 1,010.41%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel